BGI Genomics is the world’s leading provider of genomic sequencing services and proteomic services, now serving customers in more than 100 countries. We provide academic institutions, pharmaceutical companies, health care providers and other organizations with integrated genomic sequencing and proteomic services and solutions across a broad range of applications spanning:
• Basic research covering human, plant, animal and microbial species
• Clinical research in human health
• Genetic testing and screening
• Drug discovery and development
• Agriculture and Biodiversity preservation and sustainability
We have more than 20 years of genomics experience helping our customers achieve their research goals by delivering rapid, high quality results using a broad array of cost-effective, cutting-edge technologies, including our own innovative DNBseq™ sequencing technology. Contact us to find out how we can assist with your project, we’re confident we can help.
We provide sequencing services on cutting-edge next generation sequencing (NGS) platforms, including proprietary DNBSEQ™ technology platforms offering quality data at unrivalled pricing for a wide variety of sequencing services and clinical applications.
We offer one of the industry’s largest sequencing capacities and have a wide variety of other NGS platforms to meet all our customers’ needs. Our technology, sequencing, capacity, and almost 20 years of genomics experience allow us to offer our customers customers and partners a trusted, cost efficient and expert service for all outsourced sequencing needs.
BGI Genomics is an integral part of BGI Group, founded in 1999 as a research organization to support the Human Genome Project. Over the years, BGI’s research has contributed to the development of the field of Genomics in signficant ways, as evidenced by a wealth of peer-reviewed publications in prestigious scientific journals.
Today, BGI is actively participating in the fields of Cancer Research, Bio-sustainability and Personalized Medicine through a variety of subsidiaries and a global network of collaborators.